Morgan Stanley Cuts Edwards Lifesciences (NYSE:EW) Price Target to $80.00
Edwards Lifesciences (NYSE:EW – Free Report) had its target price cut by Morgan Stanley from $102.00 to $80.00 in a research report report published on Monday morning, Benzinga reports. They currently have an overweight rating on the medical research company’s stock. Other research analysts also recently issued research reports about the stock. Citigroup dropped their […]
More Stories
AllianceBernstein Global High Income Fund (NYSE:AWF) Sees Significant Growth in Short Interest
AllianceBernstein Global High Income Fund (NYSE:AWF – Get Free Report) was the target of a large increase in short interest...
Clean TeQ (OTCMKTS:CTEQF) Trading 6.7% Higher – Time to Buy?
Clean TeQ Holdings Limited (OTCMKTS:CTEQF – Get Free Report) shares traded up 6.7% during mid-day trading on Monday . The...
Silverback Therapeutics (NASDAQ:SBTX) Trading Down 1.7% – Should You Sell?
Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report)’s share price was down 1.7% during mid-day trading on Monday . The...
AdvisorShares Vice ETF (NYSEARCA:VICE) Trading Up 0.8% – Here’s What Happened
AdvisorShares Vice ETF (NYSEARCA:VICE – Get Free Report)’s share price traded up 0.8% during trading on Monday . The company...
Helius Medical Technologies (NASDAQ:HSDT) Trading Up 4.8% – Time to Buy?
Helius Medical Technologies, Inc. (NASDAQ:HSDT – Get Free Report)’s stock price traded up 4.8% during trading on Monday . The...
Short Interest in Maanshan Iron & Steel Company Limited (OTCMKTS:MAANF) Expands By 17,200.0%
Maanshan Iron & Steel Company Limited (OTCMKTS:MAANF – Get Free Report) was the recipient of a large growth in short...